AU2002359984A1 - Salmonella antigen formulation and antibody test kit and subunit vaccine using the same - Google Patents

Salmonella antigen formulation and antibody test kit and subunit vaccine using the same

Info

Publication number
AU2002359984A1
AU2002359984A1 AU2002359984A AU2002359984A AU2002359984A1 AU 2002359984 A1 AU2002359984 A1 AU 2002359984A1 AU 2002359984 A AU2002359984 A AU 2002359984A AU 2002359984 A AU2002359984 A AU 2002359984A AU 2002359984 A1 AU2002359984 A1 AU 2002359984A1
Authority
AU
Australia
Prior art keywords
same
test kit
subunit vaccine
antibody test
antigen formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002359984A
Inventor
Tomoya Ekawa
Hiroaki Ohta
Yukiko Toyata
Satoru Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CAF LABORATORIES Inc
Original Assignee
CAF LAB Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CAF LAB Inc filed Critical CAF LAB Inc
Publication of AU2002359984A1 publication Critical patent/AU2002359984A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • G01N2333/255—Salmonella (G)
AU2002359984A 2002-12-16 2002-12-16 Salmonella antigen formulation and antibody test kit and subunit vaccine using the same Abandoned AU2002359984A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2002/013148 WO2004055045A1 (en) 2002-12-16 2002-12-16 Salmonella antigen formulation and antibody test kit and subunit vaccine using the same

Publications (1)

Publication Number Publication Date
AU2002359984A1 true AU2002359984A1 (en) 2004-07-09

Family

ID=32587948

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002359984A Abandoned AU2002359984A1 (en) 2002-12-16 2002-12-16 Salmonella antigen formulation and antibody test kit and subunit vaccine using the same

Country Status (3)

Country Link
JP (1) JPWO2004055045A1 (en)
AU (1) AU2002359984A1 (en)
WO (1) WO2004055045A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI353252B (en) * 2004-04-28 2011-12-01 Cms Peptides Patent Holding Company Ltd Biologically active peptide vapeehptllteaplnpk der
CN103837684A (en) * 2014-03-27 2014-06-04 扬州大学 Antibody reagent for rapidly detecting salmonellas and detection method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989010967A1 (en) * 1988-05-05 1989-11-16 Praxis Biologics, Inc. Recombinant flagellin vaccines
AU4709401A (en) * 1999-11-29 2001-06-12 Inotek Corporation Composition and method for treating a microbial infection

Also Published As

Publication number Publication date
JPWO2004055045A1 (en) 2006-04-20
WO2004055045A1 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
IL207028A0 (en) Pharmaceutical nati-tnf-alpha antibody formulation
IL228034A0 (en) High concentration antibody and protein formulations
PL2218461T3 (en) CD40 antibody formulation and methods
AU2002249914A1 (en) Allergen and irritant measuring device
AU2003231352A1 (en) Biocidal formulation and methods for the preparation thereof
AU2002365228A1 (en) Antigen panels and methods of using the same
AU2003224313A1 (en) Mycobacterial antigens and uses thereof
WO2005065382A8 (en) Polypeptides and immunogenic conjugates capable of inducing antibodies against pathogens, and uses thereof
AU2003283963A1 (en) Mage-c2 antigenic peptides and uses thereof
EP1589033A4 (en) Antibody and use thereof
EP1534332A4 (en) Antibodies and uses thereof
AU2003267361A1 (en) Orthopoxvirus antigens and use thereof
AU2002359984A1 (en) Salmonella antigen formulation and antibody test kit and subunit vaccine using the same
AU2003276844A1 (en) Formulations of modified antibodies and methods of making the same
AU2003284597A1 (en) Apoptosis-associated protein and use thereof
AU2002365187A1 (en) Epitope synchronization in antigen presenting cells
AU2001261534A1 (en) The meca-79 antigen and related methods
AU2002325783A1 (en) Vaccine formulation potentiated by the combination of a DNA and an antigen
AU2002340850A1 (en) Antigen mimotopes and vaccine against cancers
AU2002350661A1 (en) Diagnostic device and kit
AU2003213167A1 (en) Sequence analysis of the tetravalent rotavirus vaccine
AU2003251398A1 (en) Novel bartonella antigen lysate extracts for use in elisa diagnostic
AU2003224761A1 (en) Mcp-1 mutant proteins, antibodies, compositions, methods and uses
AU2003280992A1 (en) Novel proteins and use thereof
AU2003211292A1 (en) Monoclonal antibody against human hepatoma and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase